Pharmicell Co Ltd
KRX:005690
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pharmicell Co Ltd
Accrued Liabilities
Pharmicell Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharmicell Co Ltd
KRX:005690
|
Accrued Liabilities
₩1.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
63%
|
CAGR 10-Years
30%
|
|
|
Celltrion Inc
KRX:068270
|
Accrued Liabilities
₩191.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Accrued Liabilities
₩52.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accrued Liabilities
₩449.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accrued Liabilities
₩375m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accrued Liabilities
₩462.2m
|
CAGR 3-Years
36%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Pharmicell Co Ltd
Glance View
Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. The company is headquartered in Seoul, Seoul and currently employs 127 full-time employees. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. The company also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.
See Also
What is Pharmicell Co Ltd's Accrued Liabilities?
Accrued Liabilities
1.9B
KRW
Based on the financial report for Dec 31, 2025, Pharmicell Co Ltd's Accrued Liabilities amounts to 1.9B KRW.
What is Pharmicell Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
30%
Over the last year, the Accrued Liabilities growth was 149%. The average annual Accrued Liabilities growth rates for Pharmicell Co Ltd have been 43% over the past three years , 63% over the past five years , and 30% over the past ten years .
